학술논문

Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR)
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 1 2014, 32 4, 1p. Supplement: S
Subject
Language
English
ISSN
15277755